| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |